{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:20:18Z","timestamp":1767140418717,"version":"build-2238731810"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2014,7,27]],"date-time":"2014-07-27T00:00:00Z","timestamp":1406419200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s00277-014-2154-5","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T21:09:21Z","timestamp":1406322561000},"page":"2045-2050","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Response to hydroxycarbamide in pediatric \u03b2-thalassemia intermedia: 8\u00a0years\u2019 follow-up in Egypt"],"prefix":"10.1007","volume":"93","author":[{"given":"Amal","family":"El-Beshlawy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"El-Ghamrawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona Abou","family":"EL-Ela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadwa","family":"Said","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Adolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdel-Rahman Ahmed","family":"Abdel-Razek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rania Ismail","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina","family":"Abdel-Salam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,27]]},"reference":[{"key":"2154_CR1","doi-asserted-by":"crossref","DOI":"10.1002\/9780470696705","volume-title":"The thalassemia syndromes","author":"DJ Weatherall","year":"2001","unstructured":"Weatherall DJ, Clegg JB (2001) The thalassemia syndromes, 4th edn. Blackwell Science, Oxford, United Kingdom","edition":"4"},{"key":"2154_CR2","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJMra050436","volume":"353","author":"D Rund","year":"2005","unstructured":"Rund D, Rachmilewitz E (2005) \u03b2-thalassemia. N Engl J Med 353:1135\u20131146","journal-title":"N Engl J Med"},{"issue":"4","key":"2154_CR3","first-page":"22","volume":"75","author":"R Najar","year":"2004","unstructured":"Najar R, Kaspar H, Shabaklo H, Makhoul N, Zalloua O (2004) Accurate and rapid prenatal diagnosis of the most frequent East Mediterranean \u03b2-thalassemia mutations. Am J Hematol 75(4):22\u201324","journal-title":"Am J Hematol"},{"key":"2154_CR4","doi-asserted-by":"crossref","unstructured":"Thein SL (2005) Pathophysiology of \u00df-thalassemia\u2014A guide to molecular therapies: Hematology; (1) 31","DOI":"10.1182\/asheducation-2005.1.31"},{"key":"2154_CR5","first-page":"133","volume-title":"The thalassaemia syndromes","author":"DR Higgs","year":"2001","unstructured":"Higgs DR, Thein SL, Woods WG (2001) The molecular pathology of the thalassaemias. In: Weatherall DJ, Clegg B (eds) The thalassaemia syndromes, 4th edn. Blackwell Science, Oxford, England, pp 133\u2013191","edition":"4"},{"issue":"5","key":"2154_CR6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.21120","volume":"83","author":"A Koren","year":"2008","unstructured":"Koren A, Levin C, Dgany O, Kransnov T, Elhasid R, Zalman L, Palmor H, Tamary H (2008) Response to hydroxyurea therapy in \u03b2-thalassemia. Am J Hematol 83(5):366\u2013370","journal-title":"Am J Hematol"},{"issue":"3","key":"2154_CR7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.1995.tb05584.x","volume":"90","author":"YT Zeng","year":"1995","unstructured":"Zeng YT, Huang SZ, Ren ZR, Lu ZH, Zeng FY, Schechter AN, Rodgers GP (1995) Hydroxyurea therapy in beta-thalassaemia intermedia: improvement in haematological parameters due to enhanced beta-globin synthesis. Br J Hematol 90(3):557\u2013563","journal-title":"Br J Hematol"},{"key":"2154_CR8","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","volume":"102","author":"M Bradai","year":"2003","unstructured":"Bradai M, Abad MT, Pissard S et al (2003) Hydroxyurea can eliminate transfusion requirements in children with severe \u03b2-thalassemia. Blood 102:1529\u20131530","journal-title":"Blood"},{"key":"2154_CR9","first-page":"1172","volume":"89","author":"M Yavarian","year":"2004","unstructured":"Yavarian M, Karimi M, Bakker E et al (2004) Response to hydroxyurea treatment in Iranian transfusion-dependent b-thalassemia patients. Haematologica 89:1172\u20131178","journal-title":"Haematologica"},{"key":"2154_CR10","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00277-003-0836-5","volume":"83","author":"M Alebouyeh","year":"2004","unstructured":"Alebouyeh M, Moussavi F, Haddad-Deylami H et al (2004) Hydroxyurea in the treatment of major b-thalassemia and importance of genetic screening. Ann Haematol 83:430\u2013433","journal-title":"Ann Haematol"},{"key":"2154_CR11","first-page":"58","volume":"80","author":"C Camaschella","year":"1995","unstructured":"Camaschella C, Cappellini MD (1995) Thalassemia intermedia. Molecular basis of disease. Haematologica 80:58\u201368","journal-title":"Haematologica"},{"issue":"9","key":"2154_CR12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jcp.46.9.852","volume":"46","author":"GB Tan","year":"1993","unstructured":"Tan GB, Aw TC, Dunstan RA, Lee SH (1993) Evaluation of high performance liquid chromatography for routine estimation of haemoglobins A2 and F. J Clin Pathol 46(9):852\u2013856","journal-title":"J Clin Pathol"},{"issue":"1","key":"2154_CR13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/humu.1380020109","volume":"2","author":"IR Hussein","year":"1993","unstructured":"Hussein IR, Temtamy SA, El-Beshlawy A, Fearon C, Shalaby Z, Vassilopoulos G, Kazazian HH (1993) Molecular characterization of \u03b2-thalassemia in Egyptians. Hum Mutat 2(1):488\u2013452","journal-title":"Hum Mutat"},{"issue":"1","key":"2154_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/03630260601057104","volume":"31","author":"S El-Gawhary","year":"2007","unstructured":"El-Gawhary S, El-Shafie S, Niazi M, Aziz M, El-Beshlawy A (2007) Study of beta-Thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian Thalassemia patients. Hemoglobin 31(1):63\u201369","journal-title":"Hemoglobin"},{"key":"2154_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00277-005-1026-4","volume":"84","author":"A Dixit","year":"2005","unstructured":"Dixit A, Chatterjee TT, Mishra P et al (2005) Hydroxyurea in thalassemia intermedia\u2014a promising therapy. Ann Hematol 84:441\u2013446","journal-title":"Ann Hematol"},{"key":"2154_CR16","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJM199505183322001","volume":"332","author":"S Charache","year":"1995","unstructured":"Charache S, Terrin ML, Moore RD et al (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med 332:1317\u20131322","journal-title":"N Engl J Med"},{"key":"2154_CR17","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","volume":"289","author":"MH Steinberg","year":"2003","unstructured":"Steinberg MH, Barton F, Castro O et al (2003) Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: Risks and benefits up to 9\u00a0years of treatment. JAMA 289:1645\u20131651","journal-title":"JAMA"},{"key":"2154_CR18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.1998.tb10469.x","volume":"850","author":"D Loukopoulos","year":"1998","unstructured":"Loukopoulos D, Voskaridou E, Stamoulakatou A et al (1998) Hydroxyurea therapy in thalassemia. Ann N Y Acad Sci 850:120\u2013128","journal-title":"Ann N Y Acad Sci"},{"key":"2154_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1749-6632.1998.tb10521.x","volume":"850","author":"L Styles","year":"1998","unstructured":"Styles L, Lewis B, Foote D et al (1998) Preliminary report: hydroxyurea produces significant clinical response in thalassemia intermedia. Ann N Y Acad Sci 850:461\u2013462","journal-title":"Ann N Y Acad Sci"},{"key":"2154_CR20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/(SICI)1096-8652(199912)62:4<221::AID-AJH4>3.0.CO;2-R","volume":"62","author":"C Hoppe","year":"1999","unstructured":"Hoppe C, Vichinsky E, Lewis B, Foote D, Styles L (1999) Hydroxyurea and sodium phenylbutyrate therapy in thalassemia intermedia. Am J Hematol 62:221\u2013227","journal-title":"Am J Hematol"},{"key":"2154_CR21","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/01.mph.0000174386.13109.28","volume":"27","author":"M Karimi","year":"2005","unstructured":"Karimi M, Darzi H, Yavarian M (2005) Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6\u00a0years of therapy in Iran. J Pediatr Hematol Oncol 27:380\u2013385","journal-title":"J Pediatr Hematol Oncol"},{"issue":"8","key":"2154_CR22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3109\/08880010903271671","volume":"26","author":"MA Ehsani","year":"2009","unstructured":"Ehsani MA, Hedayati-Asl AA, Bagheri A, Zeinali S, Rashidi A (2009) Hydroxyurea-induced hematological response in transfusion-independent beta thalassemia intermedia: case series and review of literature. Pediatr Hematol Oncol 26(8):560\u2013565","journal-title":"Pediatr Hematol Oncol"},{"key":"2154_CR23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-2141.2001.03042.x","volume":"114","author":"YP Chang","year":"2001","unstructured":"Chang YP, Littera R, Garau R et al (2001) The role of heterocellular hereditary persistence of fetal haemoglobin in \u03b20-thalassaemia intermedia. Br J Haematol 114:899\u2013906","journal-title":"Br J Haematol"},{"issue":"10","key":"2154_CR24","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1111\/j.1537-2995.2007.01399.x","volume":"47","author":"M Bradai","year":"2007","unstructured":"Bradai M, Pissard S, Abad MT, Dechartres A, Ribeil JA, Landais P, De Montalembert M (2007) Decreased transfusion needs with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia. Transfusion 47(10):1830\u20131836","journal-title":"Transfusion"},{"key":"2154_CR25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1182\/blood.V85.4.1111.bloodjournal8541111","volume":"85","author":"YC Cang","year":"1995","unstructured":"Cang YC, Smith KD, Moore RD, Serjeant GR, Dover GJ (1995) An analysis of fetal haemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, b-globin haplotype, a-globin gene number, gender and age. Blood 85:1111\u20131117","journal-title":"Blood"},{"key":"2154_CR26","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1182\/blood.V95.1.360","volume":"95","author":"SS Chong","year":"2000","unstructured":"Chong SS, Boehm CD, Higgs DR, Cutting GR (2000) Single tube multiplex-PCR screen for common deletional determinants of \u03b1-thalassemia. Blood 95:360\u2013362","journal-title":"Blood"},{"key":"2154_CR27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM198206173062402","volume":"306","author":"DR Higgs","year":"1982","unstructured":"Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatheral DJ, Hayes RJ et al (1982) Interaction of alpha-thalassemia and homozygous sickle-cell disease. N Engl J Med 306:1441\u20131446","journal-title":"N Engl J Med"},{"key":"2154_CR28","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1046\/j.1365-2141.2002.03958.x","volume":"119","author":"M Wang","year":"2002","unstructured":"Wang M, Tang DC, Liu W, Chin K, Zhu JG, Fibach E et al (2002) Hydroxyurea exerts bimodal dose-dependent effects on erythropoiesis in human cultured erythroid cells via distinct pathways. Br J Haematol 119:1098\u20131105","journal-title":"Br J Haematol"},{"key":"2154_CR29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/10245330400020439","volume":"10","author":"I Panigrahi","year":"2005","unstructured":"Panigrahi I, Dixit A, Arora S et al (2005) Do alpha deletions influence hydroxyurea response in thalassemia intermedia? Hematology 10:61\u201366","journal-title":"Hematology"},{"issue":"1\u20132","key":"2154_CR30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2009.06.019","volume":"407","author":"KY Italia","year":"2009","unstructured":"Italia KY, Jijina FJ, Merchant R et al (2009) Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India. Clin Chim Acta 407(1\u20132):10\u201315","journal-title":"Clin Chim Acta"},{"issue":"3","key":"2154_CR31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/08880011003639952","volume":"27","author":"M Karimi","year":"2010","unstructured":"Karimi M, Cohan N, Moosavizadeh K, Falahi MJ, Haghpanah S (2010) Adverse effects of hydroxyurea in \u03b2-thalassemia intermedia patients: 10\u00a0years\u2019 experience. Pediatr Hematol Oncol 27(3):205\u2013211","journal-title":"Pediatr Hematol Oncol"}],"updated-by":[{"DOI":"10.1007\/s00277-016-2635-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T00:00:00Z","timestamp":1457913600000}}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2154-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-014-2154-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-014-2154-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,22]],"date-time":"2020-08-22T12:25:54Z","timestamp":1598099154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-014-2154-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,27]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2154"],"URL":"https:\/\/doi.org\/10.1007\/s00277-014-2154-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,27]]}}}